Isagenix Co-Founder and President Jim Coover and Master Formulator John Anderson
have just revealed a new formulation of Product B® available for the ANZ market! This fourth generation of Product B is so improved, it comes with a new name—Product B IsaGenesis—and it’s scientifically designed to deliver the optimal levels of active ingredients targeted to support telomere health.
“Isagenix® cares about telomere health and we are committed to be in the forefront of this science using natural products, not drugs,” said Jim Coover during the reveal. Product B IsaGenesis aims to help telomeres do what they do best—protect your DNA, your cells and help you age healthily.
“Besides being one of the best telomere support products on the planet,” said John Anderson, “IsaGenesis is also a very powerful antioxidant, which benefits the liver and the brain.”
Outstanding New Improvements
- 20 percent more active ingredients
- Ingredients added to enhance absorption
- Also supports liver, kidney and brain health, cell integrity and healthy circulation
The new formulation boasts another improvement: It’s now a softgel, making it easier to swallow and superior in terms of absorption of the active ingredients. “All Isagenix products are formulated with these fundamental objectives in mind,” said John Anderson. He also shared the origin of the product’s new name, saying, “I always knew the name would change someday as the product evolved. Genesis means the coming into being of something, it means the origin. And that is exactly what IsaGenesis is as Isagenix leads the way to telomere health—now and in the future.”
University Study Support for Product B
Finding an accurate and predictable way of determining telomere length is something scientists are working to solve. In the meantime, there are some markers of healthy aging that can help determine efficacy. Jim Coover emphasised the Isagenix commitment to research, saying “scientific validation is very important to us, because we want you to know that every Isagenix product is effective.” To understand how Product B makes an impact on healthy ageing, Isagenix partnered with Arizona State University to measure catalase, a marker of healthy aging, and determine how this important indicator is affected by Product B, and ultimately, Product B IsaGenesis. The early results of the randomised, double-blind, placebo-controlled trial were shared by Chief Science Officer Suk Cho, Ph.D. You can learn more about the trial design and results at IsagenixHealth.net.
Keep an eye out on ANZ.IsaFYI for more details on Product B IsaGenesis soon!
